BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,039,495 | +2.9% | 289,701 | +21.9% | 0.01% | 0.0% |
| Q1 2023 | $1,981,709 | -8.2% | 237,615 | +26.4% | 0.01% | -12.5% |
| Q4 2022 | $2,158,229 | +3.6% | 187,999 | +13.7% | 0.01% | 0.0% |
| Q3 2022 | $2,083,000 | -21.1% | 165,341 | -33.8% | 0.01% | -20.0% |
| Q2 2022 | $2,641,000 | +14.1% | 249,639 | +75.3% | 0.01% | +42.9% |
| Q1 2022 | $2,315,000 | -29.2% | 142,377 | -39.7% | 0.01% | -22.2% |
| Q4 2021 | $3,272,000 | +23.1% | 236,217 | +27.8% | 0.01% | +12.5% |
| Q3 2021 | $2,657,000 | -2.8% | 184,890 | +6.9% | 0.01% | -11.1% |
| Q2 2021 | $2,734,000 | +168.8% | 172,901 | +72.9% | 0.01% | +125.0% |
| Q1 2021 | $1,017,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |